(19)
(11) EP 4 436 620 A2

(12)

(88) Date of publication A3:
06.07.2023

(43) Date of publication:
02.10.2024 Bulletin 2024/40

(21) Application number: 22896250.2

(22) Date of filing: 22.11.2022
(51) International Patent Classification (IPC): 
A61L 27/24(2006.01)
C08L 5/08(2006.01)
A61K 31/728(2006.01)
A61L 27/52(2006.01)
A61K 38/39(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0048; A61K 47/42; A61K 47/36; A61K 9/06; A61K 31/375; A61L 2430/16; A61L 27/20; A61L 27/24; A61L 27/54; A61L 2300/428
 
C-Sets:
A61L 27/20, C08L 5/08;
(86) International application number:
PCT/TR2022/051336
(87) International publication number:
WO 2023/091120 (25.05.2023 Gazette 2023/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.11.2021 TR 202118218

(71) Applicant: VSY Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi
Tuzla/Istanbul (TR)

(72) Inventors:
  • CAN, Efe
    Tuzla/Istanbul (TR)
  • OYTUN, Faruk
    Tuzla/Istanbul (TR)
  • KAYA, Busra Gizem
    Tuzla/Istanbul (TR)

(74) Representative: Dericioglu, E. Korhan 
Ankara Patent Bureau Mustafa Kemal Mahallesi Dumlupinar Bulvari Eskisehir Yolu 9.km No:274/7 B Blok 14. Kat No:161, Cankaya
34707 Ankara
34707 Ankara (TR)

   


(54) A HYDROGEL FORMULATION USED AS VITREOUS SUBSTITUTE AND PRODUCTION METHOD THEREOF